Home » Advisory Panel Splits Over Expanded Indications for Medtronic’s CRT Line
Advisory Panel Splits Over Expanded Indications for Medtronic’s CRT Line
A divided Circulatory System Devices Panel grappled with fine distinctions in risk-benefit tradeoffs before voting to expand use of two Medtronic heart failure products to treat patients with atrial ventricular block and reduced heart function. The question on the table Tuesday was whether Medtronic’s Cardiac Resynchronization Therapy-Pacemaker (CRT-P) and Cardiac Resynchronization Therapy-Defibrillator (CRT-D) should be indicated for use in patients.
Devices & Diagnostics Letter
Devices & Diagnostics Letter
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May